Commercial Manufacturing

Commercial manufacturing is the ultimate goal to reach with our clients as a contract manufacturer.

The PolyPeptide Group produces around one half of the commercially approved peptides in the world. Our experience in process development, manufacturing scale up, and regulatory filing makes us a trusted and reliable partner to our clients.

Whether your product is an orphan drug with limited regulatory requirements, a therapeutic with large quantities required, or a peptide vaccine with specific challenges, the PolyPeptide Group has the knowledge and experience to assist in every step of the approval cycle.